Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy
Clinical trial NCT01437566 · COMPLETED
Trial details
- NCT number
- NCT01437566
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2016-04-01
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.